Supplement industry news and updates – August 2024

Plan more strategically for increasingly sophisticated active nutrition consumers

New SPINS research reveals how fitness fans are targeting different phases of their workout with different ingredients. Learn how condition-specific strategies for pre-, intra- and post-workout ingredients can push your sales ahead of the new product peloton here.

The quality supplement industry: Created for health, validated with science – video
Consumers want dietary supplements that work for them and they’re willing to pay more for those that are clinically proven. In this new video from Inside the Bottle, Radicle Science Co-Founder and Executive Chair Pelin Thorogood addresses the path to gaining and keeping consumer trust –– explaining that properly designed trials and transparent communication and access to efficacy data, for retailers and consumers alike, are critical to supporting industry quality and consumer trust. Watch here.

NBJ releases new Condition Specific Report — research

Arm yourself with the latest data and analysis of the top 22 conditions driving supplement sales — and the ingredients that target them — with the brand new NBJ Condition Specific Report. Then, explore innovations, opportunities and challenges in the exploding mushroom market in the new NBJ Mushroom Market Report, including a special psilocybin feature.

Sen. Durbin reintroduces Dietary Supplement Listing Act — article

Durbin reintroduced a 2024 version of the bill he failed to push through Congress in 2022, claiming FDA cannot effectively regulate or police the market if it does not know the extent of all supplements sold in the U.S. Learn what the bill requires of companies and keep up with industry’s response on Natural Products Insider.

Death spurs another FDA kratom warning — article

On July 26, FDA disclosed recently receiving an adverse event report of an individual who died after using OPMS Black Liquid Kratom. As result, FDA issued a consumer advisory warning consumers not to use the product. It reinforced its position that the botanical cannot be lawfully marketed as a dietary supplement. Read more here.